KTTA vs GILD: Which Stock is Better?
Side-by-side comparison of Pasithea Therapeutics Corp and Gilead Sciences Inc in 2026
KTTA
Pasithea Therapeutics Corp
$0.72
GILD
Gilead Sciences Inc
$131.10
Key Metrics Comparison
| Metric | KTTA | GILD | Winner |
|---|---|---|---|
| Market Cap | $23.90M | $166.90B | GILD |
| P/E Ratio | N/A | 18.29 | GILD |
| EPS (TTM) | $N/A | $7.35 | GILD |
| Revenue Growth | 15.0% | 0.0% | KTTA |
| Gross Margin | -0.5% | 79.4% | GILD |
Analyze KTTA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KTTA or GILD a better investment?
Comparing KTTA and GILD: Pasithea Therapeutics Corp has a market cap of $23.90M while Gilead Sciences Inc has $166.90B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KTTA and GILD?
KTTA (Pasithea Therapeutics Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KTTA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KTTA or GILD?
KTTA has higher revenue growth at 15.0% vs 0.0% for GILD.
Which company is more profitable: KTTA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 79.4% compared to -0.5% for KTTA.
Which is the larger company: KTTA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $166.90B compared to $23.90M for KTTA.
Should I buy KTTA or GILD in 2026?
Both KTTA and GILD have investment merit. KTTA trades at $0.72 while GILD trades at $131.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KTTA and GILD stock?
Key differences: Market Cap ($23.90M vs $166.90B), P/E Ratio (N/A vs 18.3x), Revenue Growth (15.0% vs 0.0%), Gross Margin (-0.5% vs 79.4%).